Skip to main content
. 2021 Nov 19;13(11):1961. doi: 10.3390/pharmaceutics13111961

Table 1.

The interactions for itraconazole with drugs.

Drug The Impact of pH on Absorption Reference
Omeprazole Decrease of AUC0-24 and Cmax of itraconazole. [18]
The Impact of Interaction with CYP on Pharmacokinetic Parameters
Ibrutinib The inhibition of CYP3A4 by itraconazole results in 10-fold increase of AUC and 8.8-fold increase of Cmax for ibrutinib. [22]
Efavirenz The induction of CYP3A4 activity by efavirenz led to decrease of exposure to itraconazole and its metabolite. [24]
Atorvasatatin The inhibition of CYP3A4 by itraconazole resulted in the increase in AUC, the peak serum concentration and half-life of atorvastatin lactone. [26]
Oxycodone The inhibition of the gut and liver CYP3A4 resulted in the increase in the exposure to oxycodone via inhibition of N-demetylation. [28]
Midazolam The inhibition of CYP3A4 by itraconazole resulted in the increase in the concentration of midazolam. [29]
Alprazolam The inhibition of CYP3A4 by itraconazole resulted in the increase in AUC and prolongation of half-life of alprazolam and decrease in the oral clearance. [30]
Haloperidol Voriconazole increased of AUC of haloperidol for both genetic types—CYP2D6*10/*10 and CYP2D6*1/*1. [31]
Phenytoin The inhibition of CYP2C9 by itraconazole increased the AUC of phenytoin by 10%. [32]